149 related articles for article (PubMed ID: 9783684)
21. [Diagnostic and therapy of a severe fetal parvovirus-B19-infection with persistence of viral DNA in the mothers blood but inconspicuous serological tests. Case report].
Stenner S; Enders G; Klee A; Eiden U; Weidner A; Gonser M
Z Geburtshilfe Neonatol; 2002; 206(3):102-6. PubMed ID: 12098826
[TBL] [Abstract][Full Text] [Related]
22. [Prenatal parvovirus B19 infection in fetus].
L'ubuský M; Pospísilová D; Hyjánek J; Procházka M; Mícková I
Ceska Gynekol; 2005 Jul; 70(4):306-11. PubMed ID: 16128133
[TBL] [Abstract][Full Text] [Related]
23. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
[TBL] [Abstract][Full Text] [Related]
24. [Concentration of interleukin-6 and interleukin-12 in pregnant women infected and noninfected with parvovirus B19].
Friedek D; Romanik M; Rogala-Zawada D; Mercik R; Kłuciński P
Wiad Lek; 2001; 54(9-10):492-7. PubMed ID: 11816291
[TBL] [Abstract][Full Text] [Related]
25. A prospective study of antibodies against parvovirus B19 in pregnancy.
Skjöldebrand-Sparre L; Fridell E; Nyman M; Wahren B
Acta Obstet Gynecol Scand; 1996 Apr; 75(4):336-9. PubMed ID: 8638451
[TBL] [Abstract][Full Text] [Related]
26. Parvovirus B19 infections in pregnancy.
Markenson GR; Yancey MK
Semin Perinatol; 1998 Aug; 22(4):309-17. PubMed ID: 9738995
[TBL] [Abstract][Full Text] [Related]
27. Pathogenesis of nonimmune hydrops fetalis caused by intrauterine B19 infection.
Yaegashi N
Tohoku J Exp Med; 2000 Feb; 190(2):65-82. PubMed ID: 10770616
[TBL] [Abstract][Full Text] [Related]
28. [Observations on human parvovirus B19 infection diagnosed in 2011].
Mihály I; Trethon A; Arányi Z; Lukács A; Kolozsi T; Prinz G; Marosi A; Lovas N; Dobner IS; Prinz G; Szalai Z; Pék T
Orv Hetil; 2012 Dec; 153(49):1948-57. PubMed ID: 23204301
[TBL] [Abstract][Full Text] [Related]
29. A clinical and epidemiological study of human parvovirus B19 infection in fetal hydrops using PCR Southern blot hybridization and chemiluminescence detection.
Wattre P; Dewilde A; Subtil D; Andreoletti L; Thirion V
J Med Virol; 1998 Feb; 54(2):140-4. PubMed ID: 9496373
[TBL] [Abstract][Full Text] [Related]
30. Maternal-fetal transmission of human parvovirus B19 genotype 3.
Candotti D; Danso K; Parsyan A; Dompreh A; Allain JP
J Infect Dis; 2006 Sep; 194(5):608-11. PubMed ID: 16897659
[TBL] [Abstract][Full Text] [Related]
31. Nonstructural protein (NS1) of human parvovirus B19 stimulates host innate immunity and blunts the exogenous type I interferon signaling in vitro.
Wu J; Chen X; Ye H; Yao M; Li S; Chen L
Virus Res; 2016 Aug; 222():48-52. PubMed ID: 27270128
[TBL] [Abstract][Full Text] [Related]
32. Incidence of parvovirus B19 infection among an unselected population of pregnant women in the Netherlands: A prospective study.
van Gessel PH; Gaytant MA; Vossen AC; Galama JM; Ursem NT; Steegers EA; Wildschut HI
Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):46-9. PubMed ID: 16406220
[TBL] [Abstract][Full Text] [Related]
33. Antibody to parvovirus B19 nonstructural protein is associated with chronic arthralgia in patients with chronic fatigue syndrome/myalgic encephalomyelitis.
Kerr JR; Gough J; Richards SC; Main J; Enlander D; McCreary M; Komaroff AL; Chia JK
J Gen Virol; 2010 Apr; 91(Pt 4):893-7. PubMed ID: 20007355
[TBL] [Abstract][Full Text] [Related]
34. Parvovirus B19 antibodies and correlates of infection in pregnant women attending an antenatal clinic in central Nigeria.
Emiasegen SE; Nimzing L; Adoga MP; Ohagenyi AY; Lekan R
Mem Inst Oswaldo Cruz; 2011 Mar; 106(2):227-31. PubMed ID: 21537685
[TBL] [Abstract][Full Text] [Related]
35. Placental cellular immune response in women infected with human parvovirus B19 during pregnancy.
Jordan JA; Huff D; DeLoia JA
Clin Diagn Lab Immunol; 2001 Mar; 8(2):288-92. PubMed ID: 11238210
[TBL] [Abstract][Full Text] [Related]
36. Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection.
Pfrepper KI; Enders M; Motz M
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):362-5. PubMed ID: 16316402
[TBL] [Abstract][Full Text] [Related]
37. Lymphocyte recognition of human parvovirus B19 non-structural (NS1) protein: associations with occurrence of acute and chronic arthropathy?
Mitchell LA; Leong R; Rosenke KA
J Med Microbiol; 2001 Jul; 50(7):627-635. PubMed ID: 11444773
[TBL] [Abstract][Full Text] [Related]
38. Long term follow up of serostatus after maternofetal parvovirus B19 infection.
Dembinski J; Eis-Hübinger AM; Maar J; Schild R; Bartmann P
Arch Dis Child; 2003 Mar; 88(3):219-21. PubMed ID: 12598382
[TBL] [Abstract][Full Text] [Related]
39. Human parvovirus B19 infection during pregnancy--value of modern molecular and serological diagnostics.
Enders M; Schalasta G; Baisch C; Weidner A; Pukkila L; Kaikkonen L; Lankinen H; Hedman L; Söderlund-Venermo M; Hedman K
J Clin Virol; 2006 Apr; 35(4):400-6. PubMed ID: 16332455
[TBL] [Abstract][Full Text] [Related]
40. Human parvovirus B19 in Iranian pregnant women: a serologic survey.
Khameneh ZR; Hanifian H; Barzegari R; Sepehrvand N
Indian J Pathol Microbiol; 2014; 57(3):442-4. PubMed ID: 25118740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
